These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14267089)

  • 1. THE USE OF HUMAN BLOOD DERIVATIVES IN A POPULATION WHERE SUCH PRODUCTS ARE READILY AVAILABLE IN ADEQUATE QUANTITY WITHOUT COST.
    ANDERSON HD
    Bibl Haematol; 1964; 19():669-75. PubMed ID: 14267089
    [No Abstract]   [Full Text] [Related]  

  • 2. A PROGRAM WHICH COORDINATES THE ACTIVITIES OF BLOOD BANKS, MATERNITY HOSPITALS, PHYSICIANS AND THE DEPARTMENT OF HEALTH LABORATORIES TO PROVIDE ALL USEFUL DERIVATIVES IN ADEQUATE QUANTITY WITH A MINIMUM OF COST TO THE RECIPIENT.
    ANDERSON HD
    Bibl Haematol; 1964; 19():664-8. PubMed ID: 14267088
    [No Abstract]   [Full Text] [Related]  

  • 3. INACTIVATION OF STREPTOKINASE BY BOVINE PLASMIN.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():529-32. PubMed ID: 14086328
    [No Abstract]   [Full Text] [Related]  

  • 4. FIBRINOGEN AS A PART OF PLATELET STRUCTURE.
    GOKCEN M; YUNIS E
    Nature; 1963 Nov; 200():590-1. PubMed ID: 14082244
    [No Abstract]   [Full Text] [Related]  

  • 5. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM.
    JACOBSEN CD
    Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017
    [No Abstract]   [Full Text] [Related]  

  • 6. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 7. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 8. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 9. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 10. A SIMPLE RAPID METHOD FOR ESTIMATING SERUM PLASMIN ACTIVITY WITH FIBRIN-COATED LATEX PARTICLES.
    FERREIRA HC
    Blood; 1965 Feb; 25():258-60. PubMed ID: 14267701
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 12. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
    AUERSWALD W; BERNHEIMER H; DOLESCHEL W
    Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888
    [No Abstract]   [Full Text] [Related]  

  • 13. THE INHIBITORY EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE AS RELATED TO PROTEOLYTIC ACTIVITY AND PROACTIVATOR FUNCTION OF HUMAN EUGLOBULIN.
    HELLE I
    Scand J Haematol; 1964; 1():240-56. PubMed ID: 14214904
    [No Abstract]   [Full Text] [Related]  

  • 14. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE].
    VAUXSAINT CYR
    Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 16. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 17. FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.
    COON WW; PENNER JA
    Surg Gynecol Obstet; 1964 Sep; 119():495-502. PubMed ID: 14210147
    [No Abstract]   [Full Text] [Related]  

  • 18. THE EFFECT OF PLASMA KININ-FORMING SUBSTRATES ON THE DELAYED REACTION TO INTRADERMAL TUBERCULIN AND STREPTOKINASE.
    GREAVES MC; SHUSTER S
    Clin Sci; 1964 Oct; 27():341-4. PubMed ID: 14220914
    [No Abstract]   [Full Text] [Related]  

  • 19. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 20. PLASMA CHANGES DURING FIBRINOLYTIC THERAPY.
    JOHNSON JF; BARNHART MI; GILROY J; MEYER JS
    Vox Sang; 1963; 8():484-8. PubMed ID: 14059845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.